Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 41, 2014, Pages E4342-E4349

  Kwun, Hyun Jin ^a   Toptan, Tuna ^a   Da Silva, Suzane Ramos ^b   Atkins, John F ^c   Moore, Patrick S ^a   Chang, Yuan ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

EBV; HHV4; HHV8; POLY Q; PRF

Indexed keywords

EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; CHEMISTRY; CYTOPLASM; EPSTEIN BARR VIRUS; GENETICS; HEK293 CELL LINE; HUMAN; HUMAN HERPESVIRUS 8; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; RIBOSOMAL FRAMESHIFTING; RNA TRANSLATION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CELL LINE, TUMOR; CYTOPLASM; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FRAMESHIFTING, RIBOSOMAL; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; READING FRAMES; REPETITIVE SEQUENCES, AMINO ACID;

EID: 84907895360     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1416122111     Document Type: Article

References (44)

1. Atkins JF, Gesteland RF (2010) Recoding: Expansion of Decoding Rules Enriches Gene Expression (Springer Verlag, New York).
2. Namy O, Moran SJ, Stuart DI, Gilbert RJ, Brierley I (2006) A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting. Nature 441(7090):244-247.
3. Flanagan JF, 4th, Namy O, Brierley I, Gilbert RJ (2010) Direct observation of distinct A/P hybrid-state tRNAs in translocating ribosomes. Structure 18(2):257-264.
4. Ivanov IP, Gesteland RF, Atkins JF (2000) Antizyme expression: A subversion of triplet decoding, which is remarkably conserved by evolution, is a sensor for an autoregulatory circuit. Nucleic Acids Res 28(17):3185-3196.
5. Fang Y, et al. (2012) Efficient -2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein. Proc Natl Acad Sci USA 109(43):E2920-E2928.
6. Chang Y, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192):1865-1869.
7. Moore PS, et al. (1996) Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 70(1):549-558.
8. Russo JJ, et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93(25):14862-14867.
9. Lieberman PM, Hu J, Renne R (2007) Gammaherpesvirus maintenance and replication during latency. Human Herpesviruses: Biology, Therapy and Immunoprophylaxis, eds Arvin A, Mocarski A, Moore PS, Roizman B, Whitley RJ (Cambridge Univ Press, Cambridge, UK), pp 379-402.
10. Ballestas ME, Chatis PA, Kaye KM (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284(5414):641-644.
11. Friborg J, Jr, Kong W, Hottiger MO, Nabel GJ (1999) p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402(6764):889-894.
12. Radkov SA, Kellam P, Boshoff C (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6(10):1121-1127.
13. Gao SJ, et al. (1996) Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335(4):233-241.
14. Rainbow L, et al. (1997) The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71(8):5915-5921.
15. Canham M, Talbot SJ (2004) A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. J Gen Virol 85(Pt 6):1363-1369.
16. Toptan T, Fonseca L, Kwun HJ, Chang Y, Moore PS (2013) Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation. J Virol 87(5):2744-2755.
17. Kwun HJ, et al. (2007) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J Virol 81(15):8225-8235.
18. Kwun HJ, et al. (2011) The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation. Virology 412(2):357-365.
19. Zaldumbide A, Ossevoort M, Wiertz EJ, Hoeben RC (2007) In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus. Mol Immunol 44(6):1352-1360.
20. Levitskaya J, et al. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375(6533):685-688.
21. Yin Y, Manoury B, Fa˚hraeus R (2003) Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301(5638):1371-1374.
22. Ossevoort M, et al. (2007) The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis. Mol Immunol 44(14):3588-3596.
23. Kosugi S, Hasebe M, Tomita M, Yanagawa H (2009) Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs. Proc Natl Acad Sci USA 106(25):10171-10176.
24. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, Atkins JF (1998) A dual-luciferase reporter system for studying recoding signals. RNA 4(4):479-486.
25. Gao SJ, et al. (1999) Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: Evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. J Infect Dis 180(5):1466-1476.
26. Ambinder RF, Mullen MA, Chang YN, Hayward GS, Hayward SD (1991) Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J Virol 65(3):1466-1478.
27. Baranov PV, Fayet O, Hendrix RW, Atkins JF (2006) Recoding in bacteriophages and bacterial IS elements. Trends Genet 22(3):174-181.
28. Firth AE, Brierley I (2012) Non-canonical translation in RNA viruses. J Gen Virol 93(Pt 7):1385-1409.
29. Hwang CB, et al. (1994) A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc Natl Acad Sci USA 91(12):5461-5465.
30. Xue SA, Jones MD, Lu QL, Middeldorp JM, Griffin BE (2003) Genetic diversity: Frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats. Mol Cell Biol 23(6):2192-2201.
31. Moon S, Byun Y, Kim HJ, Jeong S, Han K (2004) Predicting genes expressed via -1 and +1 frameshifts. Nucleic Acids Res 32(16):4884-4892.
32. Ankö ML (2014) Regulation of gene expression programmes by serine-arginine rich splicing factors. Semin Cell Dev Biol 32C:11-21.
33. Dresang LR, et al. (2011) Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: Insights on the detection and discovery of viral genes. BMC Genomics 12:625.
34. McGeoch DJ (2001) Molecular evolution of the gamma-Herpesvirinae. Philos Trans R Soc Lond B Biol Sci 356(1408):421-435.
35. Tellam JT, Lekieffre L, Zhong J, Lynn DJ, Khanna R (2012) Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1. PLoS Pathog 8(12):e1003112.
36. Tellam J, et al. (2008) Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc Natl Acad Sci USA 105(27):9319-9324.
37. Brown LY, Brown SA (2004) Alanine tracts: The expanding story of human illness and trinucleotide repeats. Trends Genet 20(1):51-58.
38. Faux NG, et al. (2005) Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res 15(4):537-551.
39. Gerber HP, et al. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263(5148):808-811.
40. Berger Z, et al. (2006) Deleterious and protective properties of an aggregate-prone protein with a polyalanine expansion. Hum Mol Genet 15(3):453-465.
41. Davies JE, Rubinsztein DC (2006) Polyalanine and polyserine frameshift products in Huntington's disease. J Med Genet 43(11):893-896.
42. Girstmair H, et al. (2013) Depletion of cognate charged transfer RNA causes translational frameshifting within the expanded CAG stretch in huntingtin. Cell Reports 3(1):148-159.
43. Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501(7465):45-51.
44. Stochmanski SJ, et al. (2012) Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models. Hum Mol Genet 21(10):2211-2218.